OpenAI’s Health Policy Play and the Safety Geometry Problem
OpenAI’s Health Policy Play and the Safety Geometry Problem OpenAI’s Health Policy Play and the Safety Geometry Problem Daily Signal — May 6, 2026…
Category
Policy & Regulation
AI governance, legislation, and the broader societal implications of the technology.
44 results in this archive
CARIS Brings Agentic AI to Clinical Research Without Code
CARIS Brings Agentic AI to Clinical Research Without Code Privacy-First Agentic AI Enters the Clinical Research Pipeline Daily Signal — April 15, 2026 TL;DR:…
Trump Officials, Bank AI, and the Reliability Stack Below LLMs
Trump Officials, Bank AI, and the Reliability Stack Below LLMs Trump Officials, Bank AI, and the Reliability Stack Below LLMs Daily Signal — April…
OpenAI’s IPO Fault Line Widens as Capital Demands Mount
OpenAI’s IPO Fault Line Widens as Capital Demands Mount – 2026-04-06 OpenAI’s IPO Fault Line Widens as Capital Demands Mount TL;DR: OpenAI’s CEO and…
Anthropic’s PAC, Meta’s Breach, and Gas-Powered AI
Anthropic’s PAC, Meta’s Breach, and Gas-Powered AI – 2026-04-04 Anthropic Enters Electoral Politics as AI Industry Confronts Security Failures and Infrastructure Costs TL;DR: Anthropic…
Aligned AI Stays Vulnerable, Agent Protocols Under Attack
Aligned AI Stays Vulnerable, Agent Protocols Under Attack – 2026-04-02 Aligned AI Stays Vulnerable, Agent Protocols Under Attack TL;DR: New research flags persistent security…
OpenAI’s $122B Round Opens AI Ownership to Retail
OpenAI’s $122B Round Opens AI Ownership to Retail – 2026-04-01 OpenAI’s $122 Billion Round Redraws the Investor Map TL;DR: OpenAI closed a $122 billion…
Pentagon Bars Anthropic, Warren Cries Retaliation
Pentagon Bars Anthropic From Defense Work — Warren Calls It Political Retaliation Daily Signal — March 24, 2026 TL;DR: The most consequential development of…
Pfizer’s Lyme Vaccine Clears Phase 2 — Regulatory Path Is Next
Pfizer and Valneva’s Lyme Vaccine Shows Durable Immune Response, But the Harder Work Begins Now Daily Signal — March 23, 2026 TL;DR: Pfizer and…